33631400-6codeAntibiotics and chemotherapeutics for dermatological use tenders
15 antibiotics and chemotherapeutics for dermatological use notices published all-time within Medicinal products for dermatology. CPV 33631400-6 classifies antibiotics and chemotherapeutics for dermatological use across European public procurement.
By the numbers
Open now
0
Notices all-time
15
Typical value (median)
€397k
€397k – €397k
Last published
19 Jan 2026
Top sources
Portal BASE8
TED Member States7
Buyer and value figures for this level are aggregated from sub-codes and may be approximate.
Frequently asked questions
- What is CPV code 33631400-6?
- CPV 33631400-6 (Antibiotics and chemotherapeutics for dermatological use) is a Common Procurement Vocabulary code used across European public procurement to classify antibiotics and chemotherapeutics for dermatological use contracts. Buyers tag notices with this code so suppliers can find relevant tenders.
- How many antibiotics and chemotherapeutics for dermatological use tenders are open right now?
- There are no open antibiotics and chemotherapeutics for dermatological use (CPV 33631400-6) tenders right now, but 15 notices have been published all-time — new ones appear regularly.
- What is the typical value of a antibiotics and chemotherapeutics for dermatological use contract?
- The median estimated value of a antibiotics and chemotherapeutics for dermatological use (CPV 33631400-6) contract is around €396,866.58. Values vary widely by buyer and scope.
- Where are antibiotics and chemotherapeutics for dermatological use tenders published?
- Antibiotics and chemotherapeutics for dermatological use (CPV 33631400-6) notices are aggregated from sources including Portal BASE, TED Member States, alongside other European procurement portals tracked by Tender Radar.
Track antibiotics and chemotherapeutics for dermatological use tenders automatically
Tender Radar monitors CPV 33631400-6 tenders across 15+ European procurement portals and matches them to your company profile. Get relevant antibiotics and chemotherapeutics for dermatological use opportunities delivered as they publish.